Expert shares the promising potential of linvoseltamab in treating high-risk smoldering multiple myeloma.
Paula Rodriguez-Otero, MD, PhD
Advertisement
Articles by Paula Rodriguez-Otero, MD, PhD
Experts discuss the potential of linvoseltamab in treating high-risk smoldering multiple myeloma, highlighting promising early trial results and response rates.
Advertisement
Latest Updated Articles
IMS 2025: Pharmacist Perspectives on Safety, Early Treatment, and Education in Multiple MyelomaPublished: September 23rd 2025 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Announces Recall 580,000 Bottles of Prazosin Over Potential Carcinogenic Impurity
2
COVID-19 Reinfection Heightens Risk of Postacute Sequelae of SARS-CoV-2 in Pediatrics
3
Doxecitine–Doxribtimine Becomes First Approved Treatment for Rare Genetic Disorder
4
RSV May Complicate Multiple Myeloma Care Through Therapy Delays, Not Mortality Risk
5
